OCTANE: Adjuvant Liposomal Doxorubicin and Carboplatin for Early-stage Triple-negative Breast Cancer
Clinical trial NCT05949021 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05949021
- Sponsor
- Mridula George, MD
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-10-07
- Primary completion
- 2027-09-30
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.